immune system
N |
• in mice that are not injected with MOG peptide, thymic cellularity and appearance are similar to controls
• normal ratios of CD4+ and CD8+ thymocytes
• fractions of absolute numbers of CD4+ and CD8+ T cells in spleen and lymph nodes are similar to controls
|
• mice injected with MOG35-55 peptide have fewer B cells as compared to controls
|
• mice injected with MOG35-55 peptide have fewer CD3+ T cells in their spinal cords as compared to controls
|
• mice injected with MOG35-55 peptide have fewer CD4+ T cells as compared to controls
|
• mice injected with MOG35-55 peptide have fewer macrophages as compared to controls
|
• reduced disease severity and improved survival is observed in mice injected with MOG35-55 peptide as compared to MOG-injected wild-type mice
|
hematopoietic system
• mice injected with MOG35-55 peptide have fewer B cells as compared to controls
|
• mice injected with MOG35-55 peptide have fewer CD3+ T cells in their spinal cords as compared to controls
|
• mice injected with MOG35-55 peptide have fewer CD4+ T cells as compared to controls
|
• mice injected with MOG35-55 peptide have fewer macrophages as compared to controls
|